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Next generation genomic sequencing technologies (including whole genome or whole exome 
sequencing) are being increasingly applied to clinical care. Yet, the breadth and complexity of 
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sequencing information raise questions about how best to communicate and return sequencing 
information to patients and families in ways that facilitate comprehension and optimal health 
decisions. Obtaining answers to such questions will require multidisciplinary research. In this 
paper, we focus on how psychological science research can address questions related to clinical 
genomic sequencing by explaining emotional, cognitive, and behavioral processes in response to 
different types of genomic sequencing information (e.g., diagnostic results and incidental 
findings). We highlight examples of psychological science that can be applied to genetic 
counseling research to inform the following questions: (1) What factors influence patients' and 
providers' informational needs for developing an accurate understanding of what genomic 
sequencing results do and do not mean?; (2) How and by whom should genomic sequencing 
results be communicated to patients and their family members?; and (3) How do patients and their 
families respond to uncertainties related to genomic information?
Keywords
Communication; Genome sequencing; Patient understanding; Psychological; Psychosocial
Next generation genomic sequencing technologies (including whole genome or exome 
sequencing) have considerable potential as clinical tools because they simultaneously 
analyze millions of gene variants (Bick and Dimmock 2011; Facio, Lee, and O'Daniel 
2014). Yet, a substantial portion of the genetic variation that genomic sequencing uncovers 
is of uncertain significance due to current limitations in knowledge about genetic causes of 
disease (Berg, Khoury, and Evans 2011). Genomic sequencing can also yield incidental or 
“secondary” findings—genetic information that is unrelated to the main reason for which 
sequencing was conducted (Lohn, Adam, Birch, and Friedman 2014). Incidental findings 
vary greatly in their clinical validity and utility, and recommendations for returning this 
information will likely change with advances in genomic science (Green et al. 2013). The 
increased interest in genomic sequencing has also raised discussions regarding informed 
consent, protection of privacy, and security of health records (Burke et al. 2013; Green et al. 
2013; McGuire et al. 2008; Presidential Commission 2012).
Much of the concern surrounding return of sequencing information focuses on (a) what, 
when, how, and by whom this information should be communicated and (b) how it may be 
understood and used by patients and their family members (Berg et al. 2011; Biesecker, 
Burke, Kohane, Plon, and Zimmern 2012; Cho 2008). Genetic counselors will be on the 
frontlines of translating genomic sequencing to clinical care and grappling with these issues 
in their practice and conducting research to develop best practice guidelines (Bernhardt 
2014; Hooker, Ormond, Sweet, & Biesecker, 2014; Mills and Haga 2013; Ormond 2013). 
The aim of this paper is to provide some examples of how psychological science can inform 
multidisciplinary research on the above issues, and ultimately, provide an empirical basis for 
genetic counseling practice.
Psychological science encompasses many areas of specialization that can offer explanations 
for emotional, cognitive, and behavioral responses to sequencing information (See Table 1; 
King 2008; Patenaude, Guttmacher, and Collins 2002; Tercyak, O'Neill, Roter, and McBride 
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2012). For example, cognitive psychologists have investigated how people process 
information and make decisions; social psychologists have investigated how people 
influence each other's feelings, thoughts, and behaviors; health psychologists have 
investigated how people cope with stress; and clinical psychologists have investigated 
causes of and treatments for emotional distress. Psychological and behavioral processes 
have been investigated using people's self-reports in surveys and qualitative interviews as 
well as observations of their physiological responses (e.g., heart rate) and behavioral 
responses (e.g., information seeking) in laboratory and field settings. The variety of methods 
used in psychological science necessitates quantitative statistics and qualitative analyses to 
investigate psychological and behavioral processes. This diversity of research areas, 
methodologies, and analyses in psychological science enables genetic counseling research to 
address a wide range of practice questions related to clinical genomics.
We organize our discussion of applying psychological science to genetic counseling 
research around three critical questions that were identified by clinicians and researchers in 
the Phase 1 Clinical Sequencing Exploratory Research Program consortium (Baylor College 
of Medicine, Brigham and Women's Hospital, Children's Hospital of Philadelphia, Dana-
Farber Cancer Institute, University of North Carolina, Chapel Hill, University of 
Washington; for more information about the consortium, see http://www.genome.gov/
27546194):
1. What factors influence patients' and providers' informational needs for developing 
an accurate understanding of what genomic sequencing results do and do not 
mean?
2. How and by whom should genomic sequencing results be communicated to patients 
and their family members?
3. How do patients and their families respond to uncertainties related to genomic 
information?
Q1: What Factors Influence Patients' and Providers' Informational Needs 
for Developing an Accurate Understanding of What Genomic Sequencing 
Results Do and Do Not Mean?
Qualitative research suggests that people often anticipate some level of personal utility from 
learning sequencing information (Facio, Brooks, Loewenstein, Green, Biesecker, and 
Biesecker 2011; Miller et al. 2014; Sapp et al. 2014). Yet, people's understanding of the 
relationship of genetics to health appears to be based more on personal experiences and 
prevailing cultural views than scientific or clinical knowledge (Condit 2010). At the same 
time, the shortage of genetics specialists relative to the growing demand for clinical 
genomics (Bernhardt 2014) means that the remaining gaps are likely to be filled by 
providers with variable levels of training in genetics and genomic medicine (Feero and 
Green 2011). National surveys reveal that although most physicians recognize the potential 
benefits of genetic information for clinical care, many are ill-equipped to order genomic 
sequencing due to limitations in their genetics education and training and lack of awareness 
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of available testing resources (Haga, Burke, Ginsburg, Mills, and Agans 2012; Stanek et al. 
2012).
People have different informational needs for understanding their genomic sequencing 
information (Schmidlen, Wawak, Kasper, García-España, Christman, and Gordon 2014). 
Knowing how and what to communicate about gene variants, disease risk, and health 
implications has proven challenging (Biesecker et al. 2012; Lautenbach, Christensen, 
Sparks, and Green 2013) and will be further complicated by the return of incidental findings 
(Bernhardt 2014; Facio et al. 2014; Hooker et al. 2014). Research is needed to clarify factors 
that shape the informational needs of patients and providers for understanding genomic 
sequencing information. Elucidating such factors could, for instance, inform guidelines for 
communicating different types of sequencing information to patients; inform health care 
provider education and training; and help genetic counselors anticipate patients' needs for 
support systems or clinical services. Some examples of factors whose investigation could be 
informed by psychological science include patients' and providers' expectations for 
sequencing information; emotions surrounding sequencing information and subsequent 
decision-making; and ability to derive meaning from sequencing information.
Patient and Provider Expectations
How might patients' expectations influence their responses to sequencing results? How 
might providers' expectations influence their interpretation and communication of 
sequencing information? Expectations are characterized as beliefs about the probability of 
future outcomes (e.g., personal and social costs and benefits to engaging in a certain 
behavior; Bandura 2004) that develop largely as a result of personal and vicarious 
experiences (Olsen, Roese, and Zanna 1996). Notably, what people expect to happen may be 
distinct from what they hope will happen (Leung, Silvius, Pimlott, Dalziel, and Drummond 
2009). People's hopes for future outcomes are posited to reflect their preferred outcomes, 
which may or may not correspond with their expected outcomes. For example, a patient may 
expect and hope to get a positive result from genomic sequencing; or expect an 
uninformative result but hope for a positive result. The implications of the discrepancies 
between hopes and expectations are not yet clear.
Psychological research has shown that expectations can influence how people process 
information. When people have strong expectations for an outcome, they are likely to 
exhibit a confirmation bias—they tend to seek and attend to information that is consistent, 
rather than inconsistent, with their expectations (Bandura 2004; Hart, Albarracín, Eagly, 
Brechan, Lindberg, and Merrill 2009; Higgins and Bargh 1987; Johnston 1996). However, 
research suggests that confirmation biases can be attenuated. For example, when people 
evaluate information, diverting their focus from their expectations to the information itself 
can make their attitudes less polarized (Hernandez and Preston 2013) and decrease biased 
information-seeking (Jonas, Traut-Mattausch, Frey, and Greenberg 2008). Patient and 
provider expectations for sequencing outcomes could affect their psychological and 
behavioral responses to sequencing information. For example, patients who strongly expect 
to find a definitive genetic explanation for their condition may question the veracity of a 
negative or uninformative sequencing result. One potential implication of this response is 
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that patients may hesitate to follow medical recommendations that are based on unexpected 
sequencing results. Providers who strongly suspect a genetic cause for a disorder in their 
patient could, for example, give more clinical significance to uncertain diagnostic findings 
than warranted.
Emotions Surrounding Sequencing
How do patients' emotions surrounding different types of sequencing information influence 
their understanding and subsequent health decisions? How might providers' emotions 
surrounding sequencing information influence their willingness to order sequencing? 
Emotions are largely characterized as feelings of pleasure (e.g., happiness, relief) or 
displeasure (e.g., sadness, anger) in response to an event or experience (Barrett Feldman, 
Mesquita, Ochsner, and Gross 2007). Discussions surrounding the potential for patient 
distress in response to sequencing information typically focus on patient emotions as 
outcomes (Biesecker et al. 2012; Cho 2008). Psychological research highlights the 
importance of also investigating emotions as potential predictors of responses to 
sequencing. For example, anxiety is shown to increase people's attentiveness to threatening 
information (Vuilleumier 2005). Negative emotions (e.g., anxiety, depression) are also 
shown to motivate people to take action to blunt their distress or to avoid the source of 
distress (Frijda 1986). Patients' emotional responses to their sequencing information could 
affect how they process and seek genetic information. For example, patients who are 
distressed by their diagnostic sequencing results may avoid seeking further information 
and/or avoid discussions involving genetic information. In fact, evidence suggests that 
patients' negative emotions can undermine communication of genetic information to family 
members and uptake of genetic testing by at-risk family members (Landsbergen, Verhaak, 
Floor, and Hoogerbrugge 2005). Compared to less distressed patients, patients who are 
highly distressed may also be less willing to learn incidental information (e.g., if they fear it 
could raise additional health concerns).
Positive or negative feelings about an activity or event can also serve as “information” that 
influences people's risk perceptions and health decisions (Peters, Lipkus, and Diefenbach 
2006; Slovic, Peters, Finucane, and MacGregor 2005). Specifically, evidence suggests that 
people's judgments of an activity (e.g., cancer screening) are based, in part, on their positive 
or negative feelings about it. When people have positive feelings about activities, they view 
them as having high benefit and low risk; negative feelings about an activity have the 
opposite effects. People's feelings about an activity are theorized to precede and shape their 
beliefs about risk and benefit (Slovic et al. 2005).
Patients' feelings about receiving different types of sequencing information (e.g., negative 
diagnostic results; positive, but non-medically actionable incidental findings) may affect 
their decisions about whether or not to learn certain types of sequencing information. For 
example, patients who have positive feelings about genetic information may want to learn 
‘all the information’ they can from their genomic sequencing. Patients who feel less 
positively may be more selective about what information they want to learn. Likewise, 
providers' feelings about, for example, the possibility of needing to return incidental findings 
from diagnostic genomic sequencing (e.g., sequencing results for adult-onset diseases in 
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minors) may influence their willingness to order genomic sequencing for diagnostic 
purposes. Providers who have negative feelings about returning incidental information may 
be less willing to order genomic sequencing than providers who feel less negatively.
Further, when anticipating future emotional responses to an outcome (affective forecasting), 
people often overestimate the intensity and duration of their emotional responses to a future 
event (Wilson and Gilbert 2003). Affective forecasting has been used to highlight biases that 
can systematically shape patients' medical decisions and provider recommendations. First, 
patients may place greater weight on how they think their lives will be different than on 
what may actually stay the same after a medical diagnosis or decision. Second, patients may 
not recognize how their current emotional or physical states influence their expectations 
(Halpern and Arnold 2008; Winter, Moss, and Hoffman 2009). Third patients and providers 
may underestimate how quickly patients make sense of events and adjust their personal 
values to new situations (Halpern and Arnold 2008; Rhodes and Strain 2008; Wilson and 
Gilbert 2003). Affective forecasting could have implications for patient willingness to learn
—and provider willingness to order or return—different types of sequencing information. 
For example, patients who expect to be distressed by their genetic information may be more 
anxious about learning incidental findings out of fear of prolonged worrying afterwards. 
Conversely, patients who expect to feel more empowered may seek to learn incidental 
findings, believing that being “forewarned is forearmed.” Likewise, providers who fear 
prolonged distress or maladaptive health care decisions in patients may be hesitant to order 
genomic sequencing or return incidental findings.
Making Meaning from Complex Information
How do patients and providers infer health implications from complex sequencing 
information that is presented in the form of probabilities, patterns of inheritance, and degrees 
of penetrance? Psychological research suggests that patients and providers are unlikely to 
incorporate all of the different pieces of information regarding the sequencing output (or its 
caveats) into their interpretation of findings. For example, people often simplify complex 
information by drawing on personal experiences and anecdotal knowledge of other people's 
experiences or by comparing their situation to what they think of as a “typical situation” 
(McDowell, Occhipinti, and Chambers 2013; Tversky and Kahneman 1974). People also 
generally simplify complex information into a bottom-line meaning, or “gist” (Reyna 2008). 
Gists are also informed by context and personal experiences (e.g., “Mom and her sisters died 
from cancer, and my brother had it; cancer runs in the family; my cancer must be genetic”). 
However, when simplification of complex health information is based on inaccurate 
representations of situations, patients run the risk of maladaptive medical decision making 
(Senay and Kaphingst 2009) and providers run the risk of making ineffective or harmful 
recommendations (Enkin and Jadad 1998). Such simplifications are especially problematic 
because patients may base medical decisions more on their perceptions of their condition 
than their actual results from medical testing (Reyna 2008; Vos et al. 2012).
Examples of Research Directions for Q1
Research on such topics as expectations, emotions (and anticipated emotional responses), 
and derivation of meaning could inform an empirical basis for determining how to address 
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patients' and providers' informational needs. For example, research on expectations could 
include investigating factors that may shape patient and provider expectations to identify 
subgroups of patients and providers likely to need tailored genetics education and assistance 
with comprehension of sequencing information. Research on patients' emotions surrounding 
sequencing could include investigating patients' emotional responses—or anticipated 
responses—to different types of sequencing information and their effects on patient 
comprehension and subsequent health decision making. Research could also investigate 
provider assumptions about patients' feelings and beliefs about different types of sequencing 
and their effects on provider recommendations for genomic sequencing and provider 
communication of sequencing information. Finally, research on patients' and providers' 
inferences about health implications from sequencing information could include 
investigating how they develop a gist understanding of sequencing information to identify 
areas of misunderstanding.
Q2: How Should Genomic Sequencing Results be Communicated to 
Patients and Their Families, and from Whom Should this Communication 
Come?
The breadth and complexity of sequencing information create considerable difficulties for 
patient-provider communication and informed decision making by patients. These 
difficulties are further compounded by the interplay among the public's perceptions and 
fears about genetic information, poor health literacy, and the inability of health care systems 
and providers to keep up with advances in genomic science and medical technologies (Feero 
and Green 2011; Johnson, Case, Andrews, and Allard 2005; Lea, Kaphingst, Bowen, 
Lipkus, and Hadley 2011). Research is needed to develop guidelines for streamlining 
communication of different kinds of sequencing information (e.g., diagnostic, incidental; 
medically actionable, non-medically actionable) and develop empirically-based patient 
education strategies that maximize comprehension and informed decision making (Haga, 
Mills, and Bosworth 2014). Some examples of where psychological science could inform 
the second overarching question include research on communication formats for sequencing 
information (e.g., text, numbers, graphs); communication strategies (e.g., message framing, 
narratives, tailoring); and impact of the provider of sequencing information.
Communication Format
How can genetic counselors present genomic sequencing information in ways that are 
accessible to patients? A major challenge to communication and comprehension of 
sequencing information is that different people will have different needs for comprehending 
sequencing-related details (Schmidlen et al. 2014). For example, low patient literacy (i.e., 
inadequate knowledge and skills to search, comprehend, and use information from text or 
numbers; Kutner, Greenberg, Jin, Paulsen, and White 2006) has led to calls to investigate 
ways to communicate genetic information that take into account patient literacy levels (Lea 
et al. 2011; McBride, Koehly, Sanderson, and Kaphingst 2010). Reviews suggest that 
communication formats that can decrease literacy demands include presenting numerical 
information in tables, pictographs, and natural frequencies; avoiding overly complex 
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terminology when possible; limiting the range of information presented; starring or 
otherwise highlighting key points in text; and using videos to highlight important 
information (McCaffery et al. 2013; Trevena et al. 2013). Likewise, genetic counselors may 
benefit from using health literacy or genetic/genomic testing knowledge assessments to 
determine patients' informational needs and tailor their communication of sequencing 
information accordingly.
Communication Strategies: Message Framing
How can genetic counselors frame sequencing information in a way that promotes clinically 
appropriate decision making by patients? Health messages that encourage an action can be 
framed in terms of gains (benefits) from engaging in the action or losses (costs) from not 
engaging in the action (Gallagher and Updegraff 2012; Rothman and Salovey 1997). For 
example, smoking cessation can be framed in terms of a gain, “If you stop smoking, you'll 
reduce your chance of getting another heart attack” or in terms of a loss, “If you do not stop 
smoking, you'll increase your chance of getting another heart attack.” A recent review of 
health framing studies found that for actions intended to prevent illness (e.g., smoking 
cessation), people were on average more likely to take action in response to a gain framed 
message than to a loss framed message (Gallagher and Updegraff 2012). By contrast, for 
actions intended to detect illness or risk (e.g., mammograms), people were marginally more 
likely to take action in response to loss framed messages than gain framed messages 
(Gallagher and Updegraff 2012).
Framing effects could influence patients' responses to medically actionable sequencing 
information by, for example, influencing uptake of surveillance activities (e.g., when high 
genetic risk warrants action), treatment (e.g., when finding an explanatory gene variant leads 
to a diagnosis), or information sharing (e.g., discussing findings with other health care 
providers or family members). However, it is unclear how framing effects would influence 
patient responses to sequencing information that is not medically actionable (i.e., gene 
variants for conditions that are not preventable or do not have a well-defined treatment). 
Further, evidence suggests that framing effects on health decisions vary by patient literacy, 
health beliefs, and perceived difficulty of adhering to a recommendation (Rothman and 
Salovey 1997).
Communication Strategies: Narratives
How effective are narratives—relative to traditional genetic counseling interactions—for 
helping streamline communication of sequencing information? Narratives can be 
constructed to relate the same messages as more traditional didactic forms of health 
communication, but in a story format that describes scenes, characters, and conflict; raises 
unanswered questions or unresolved conflicts; and provides resolution to those questions 
and conflicts (Hinyard and Kreuter 2007; Kreuter et al. 2007). Stories within narratives may 
be fictional or non-fictional, and they may be based on firsthand experience, secondhand 
stories of others, a position of a group, or culturally common themes (Hinyard and Kreuter 
2007). Evidence suggests that narratives can facilitate health information processing and 
understanding, promote learning (e.g., by modeling desired behaviors), overcome resistance 
to enacting health behaviors, and help people understand the psychological and social 
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implications of health decisions (Green and Brock 2000; Kreuter et al. 2007; Murphy, 
Frank, Chatterjee, and Baezconde-Garbanati 2013). The use of narratives to promote 
understanding of genomic sequencing information and informed decision making (e.g., as 
online or written decision aid materials) could be a promising supplement to traditional 
genetic counseling interactions. However, it is currently unclear how narratives compare to 
traditional clinician-patient interactions in helping patients understand and make decisions 
based on complex and often nuanced sequencing information.
Communication Strategies: Tailoring
How can genetic counselors tailor genomic sequencing information to the patient and how 
does such tailoring affect patient understanding and health decisions? A review suggests that 
people are more likely to attend and respond to health information if its relevance is tailored 
to them (Noar, Benac, and Harris 2007). The efficacy of tailoring can be explained by 
various psychological mechanisms, including increased attention (and, by extension, 
comprehension) and greater perceived relevance to personal goals, circumstances, and 
experiences (Hawkins, Kreuter, Resnicow, Fishbein, and Dijkstra 2008). In turn, 
information perceived as more personally relevant is more likely to be carefully processed 
(e.g., greater attention to information content; greater integration of information with the 
person's own knowledge and experience; Petty and Wegener 1999).
There are numerous ways genomic sequencing information could be tailored. For example, 
information could be tailored to individual differences such as patients' need for cognition, 
which reflects the degree to which people prefer to think deeply and prefer to get more 
detailed, elaborate explanations over briefer and simpler explanations (Cacioppo and Petty 
1982). Recommendations for applying genomic information to health decisions could also 
be tailored to the individual's values, goals and life stage. Additionally, tailoring information 
to patients' level of health literacy could promote understanding of complex sequencing 
information. However, tailored approaches can be difficult to implement in some settings 
because up-front assessments are needed to guide tailoring, and providers have to be flexible 
in their style of communication (Noar et al. 2007). Nonetheless, research has documented 
effective ways to develop tailored print materials (Noar et al. 2007), and interactive web-
based software programs can facilitate baseline assessment and customized feedback (Krebs, 
Prochaska, and Rossi 2010).
The Impact of the Provider of Sequencing Information
How might patients' comprehension and subsequent use of genomic sequencing information 
vary in response to receiving them from different health care providers (e.g., genetic 
counselors, specialist, family physician)? As applications of genomic sequencing become 
widespread, there will be corresponding increases in the diversity of settings in which 
sequencing results are communicated (Bick and Dimmock 2011; Berg et al. 2011). Patients 
are more likely to trust health information from providers who are known to them and who 
they perceive as understanding their background and motivations (Kreuter and McClure 
2004; Lewis et al. 2000). Yet, the lack of uniformity in genomics education and training 
across health care professions (Feero and Green 2011) may cause some providers to refer 
patients and families to specialists with more expertise in genome medicine.
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It is currently unclear how patients would comprehend and make informed health decisions 
from sequencing information they received from different providers. Psychological science 
research on persuasive messaging suggests that people's receptivity to messages from 
different sources is influenced by a combination of source, message, and recipient factors. 
For example, for people who are highly motivated to attend to a message, evidence suggests 
that source credibility or expertise matters more when the message is ambiguous or neutral 
than when a message clearly favors a certain position (Chaiken and Maheswaran 1994). 
Evidence also suggests that when people disagree with a message, they scrutinize strongly 
argued messages from experts more than strongly argued messages from non-experts (Clark, 
Wegener, Habashi, and Evans 2012). However, when they agree with the message, people 
may scrutinize weakly argued messages more from non-experts than experts. These findings 
suggest that the difference a provider's expertise makes on patient responses to sequencing 
information could depend on factors such as the clarity of information provided or the 
degree to which the information meets patients' expectations or hopes.
Examples of Research Directions for Q2
Investigating such areas as communication formats, communication strategies (e.g., framing, 
narratives, tailoring), and impact of the provider of sequencing information could inform 
development of guidelines for communicating different types of sequencing information in 
ways that promote comprehension and informed decision making. For example, research on 
communication formats could include comparing the effects of visual aids, decision aids, 
and different communication mediums (video, online) on patient comprehension and 
decision making across different levels of literacy. Research on framing could include 
comparing the effects of gain framed to loss framed communication of diagnostic and 
incidental sequencing information on patient understanding and health decisions. Research 
on narratives could include investigating the relative efficacy of supplementing traditional 
didactic clinician-provider communication with narratives. Research on tailoring could 
include comparing the effects of different tailoring methods (e.g., by health literacy, need for 
cognition) on patient health decisions and the feasibility of applying tailoring across 
different clinical contexts. Finally, research on providers of sequencing information could 
include investigating how patient comprehension of genomic sequencing information—and 
subsequent health decisions—vary as a function of the health care provider returning results.
Q3: How do Patients and their Families Respond to Uncertainties Related 
to Genomic Information?
In health contexts, uncertainty is a multidimensional construct that is characterized as 
feeling a sense of ignorance because of the probable nature of health risks and the ambiguity 
and complexity of health information (Han, Klein, and Arora 2011). Uncertainty in health 
contexts can arise from limitations in scientific knowledge (e.g., limited evidence about a 
treatment's efficacy), limitations within health care systems (e.g., treatment accessibility), 
and patients' illness uncertainty (Han et al. 2011). Patients' illness uncertainty is 
characterized by an inability to make sense of illness-related events because patients are 
unable to identify the cause of their illness, define their illness, or make predictions about 
their future health (Han et al. 2011; Mishel 1990). Although illness uncertainty is thought to 
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be anxiety-provoking (Sweeny and Cavanaugh 2012), some patients may capitalize on it to 
allay distress from the certainty of negative health outcomes (Mishel 1990; Case, Andrews, 
Johnson, and Allard 2005). However, when patients view illness uncertainty as threatening 
or as a barrier to their goals, it can elicit distress (e.g., anxiety, depression) (Baum, 
Friedman, and Zakowski 1997; Case et al. 2005; Mishel 1990) and impede decision making 
and communication of health concerns with others (Baum et al. 1997; Hamilton et al. 2013; 
Johnson Wright, Afari, and Zautra 2009; Neville 2003). Such effects of illness uncertainty 
may depend on the source of uncertainty. For example, decisional implications of 
uncertainty about the probability of a treatment's efficacy appear to be distinct from 
decisional implications of uncertainty from a lack of information or conflicting expert 
opinions and scientific evidence (Hamilton et al. 2013).
Genomic sequencing can potentially reduce patients' illness uncertainty by identifying the 
cause of a previously unexplained or undiagnosed condition. However, genomic sequencing 
will also perpetuate illness uncertainty by yielding genetic information (diagnostic, 
incidental) with unclear clinical validity and utility; probabilistic health implications; and 
clinical implications that are likely to change over time with advances in genomic science 
(e.g., uncertain diagnostic results may be later re-classified as positive or negative results) 
(Berg et al. 2011; Green et al. 2013). Some examples of how psychological science could 
inform research on the third overarching question include clarifying how patients cope with 
uncertainty from sequencing information individually (e.g., their personal responses) and 
with others (e.g., processing information by talking with others) and their effects on patient 
psychological and behavioral responses to sequencing information. Such research could, for 
instance, inform the development of educational and support resources for patients and 
families (McClellan et al. 2013); guidelines for communicating sequencing information; and 
testable models for anticipating patient decisions about learning different types of 
sequencing information as well as their responses to receiving that information.
Individual Ways of Managing Uncertainty
How might patients respond to uncertainty in their sequencing information? In one study, 
responses to uncertainty from sequencing information by research participants were found to 
stem from their personal beliefs about the extent to which uncertainty in sequencing 
information is expected or normal (Biesecker et al. 2014). Participants with more optimistic 
attitudes or greater tolerance for ambiguity in sequencing information were more likely to 
view uncertainty as a source of opportunity. In contrast, participants who viewed uncertainty 
negatively or as something unexpected from sequencing information were more likely to 
perceive uncertainty in sequencing information as distressing or question its veracity. These 
findings suggest that patients who are more tolerant for uncertainty in sequencing 
information may be more likely to remain hopeful about the clinical possibilities of genomic 
sequencing technologies than patients who are less tolerant of uncertainty.
When uncertainty is deemed stressful, patients may engage in various efforts to manage 
their stress. One line of research on stress management suggests that people manage stress 
by either seeking or avoiding information related to the stressor. Some people tend to be 
monitors who actively seek information (e.g., scouring the Internet for relevant content), 
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believing that “knowledge is power” (Miller 1987). Other people tend to be blunters who 
avoid such information, perceiving that “ignorance is bliss”. Evidence also shows that that 
monitors are more likely than blunters to ask questions and express emotions during clinic 
encounters, have longer clinic encounters, and experience more post-decisional regret about 
treatment decisions (Timmermans, van Zuuren, van der Maazen, Leer, and Kraaimaat 2007). 
Another line of research suggests that patients may manage anxiety they experience before 
receiving uncertain health information (e.g., results from a tumor biopsy) by adjusting their 
expectations for positive outcomes, planning ways to manage distress in case of bad news, 
or finding ways to distract themselves from thinking about the impending health news 
(Sweeny and Cavanaugh 2012). Thus, such factors as individual differences in coping 
preferences and patient attempts to brace for potentially unpleasant health information could 
have important implications for how they respond to sequencing information. For example, 
relative to blunters, monitors may be more tolerant of uncertainty in their sequencing 
information and experience less distress in response to diagnostic results and incidental 
findings. Yet, blunters may be more likely to brace for potentially undesirable sequencing 
information and take precautionary measures to cushion themselves from distress.
Interpersonal Ways of Managing Uncertainty
How might family and community social dynamics influence patient responses to 
uncertainty surrounding sequencing information? Responding to illness uncertainty can 
extend beyond the individual patient to include family members. This is especially true of 
genetic information, where one family member's testing or sequencing results can impact 
how other family members view their own risk for illness (Dancyger, Smith, Jacobs, 
Wallace, and Michie 2010; McBride et al. 2010). Families often manage distress by 
encouraging disclosure of distress and engaging in collective efforts to comfort each other 
and generate potential solutions (Berg and Upchurch 2007; Mickelson, Lyons, Sullivan, and 
Coyne 2001). This shared coping often occurs when family members share a sense of 
responsibility for helping each other through difficult situations (Mickelson et al. 2001). 
These kinds of collaborative family social dynamics could, for example, facilitate exchange 
of disease-risk information within families and encourage uptake of genetic counseling or 
testing services by at-risk family members (Dancyger et al. 2010; Peterson 2005).
However, family members can also undermine each other's attempts to manage uncertainty 
by avoiding or otherwise discouraging disclosure of distress. For instance, family members 
may be uncomfortable with their loved one's distress or they may want to avoid family 
conflict regarding genetic information (Peterson 2005; Lepore and Revenson 2007). Under 
such circumstances, families may develop patterns of interaction that discourage discussion 
of personal fears and concerns. Further, some patients may prefer to keep their fears and 
concerns to themselves. For example, they may want to protect family members from 
distress, avoid discussion of difficult topics, or avoid negative experiences they had in the 
past when sharing their distress with others (Lepore and Revenson 2007; Peters et al. 2011; 
Peterson 2005). Such “social constraints” could, for example, reduce the likelihood that 
patients share important information related to family disease risk and hinder their ability to 
understand and make sense of their sequencing information.
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In addition, the ways in which patients and families respond to uncertainties related to 
genomic sequencing information could be shaped by their larger social network and 
surrounding community. When people have limited direct experience on which to base their 
expectations for future events or outcomes, they may refer to the experiences of others 
(Bandura 1997; 2004). By extension, patients and unaffected or at-risk family members may 
look to the experiences of their friends, co-workers, neighbors or fellow members of 
religious or civic organizations to inform their beliefs about genetics and its health 
implications. Further, people turn to social media (e.g., Facebook, Twitter) to increase health 
knowledge, supplement provider communication, exchange social support and advice, learn 
or share a health status, and share illness-related experiences (Antheunis, Tates, and Nieboer 
2013; Thackeray, Crookston, and West 2013). However, patients and their family members 
may need education about the potential risks of sharing sequencing information through 
social media (Prince and Roche 2014). For example, they may not realize that sharing 
sequencing information through Facebook could inadvertently undermine their or their 
family members' legal privacy protections from employers and insurers.
Examples of Research Directions for Q3
Investigating patients' individual and interpersonal coping processes surrounding sequencing 
information could provide a more nuanced understanding of patient and family responses to 
uncertainty in sequencing information. For example, research on individual coping 
processes could include investigating the effects of individual differences in patients' coping 
preferences (e.g., tendencies to be a monitor or blunter in response to distressing information 
or general coping styles) on patients' psychological responses to sequencing information, 
communication of sequencing information with others (e.g., family members, health care 
providers), and application of sequencing information to health decisions. Research on 
social dynamics surrounding genomic sequencing information could include investigating 
the effects of patient preferences for disclosure or shared decision making with close family 
members, friends, and other extended social network members on patient-level and family 
member-level psychological and behavioral outcomes. Finally, another research direction 
could be to investigate the effects of family and extended network social dynamics on 
patient psychological and behavioral responses to sequencing information as a function of 
the type of sequencing information returned (e.g., diagnostic results, incidental findings).
Conclusions
Next generation sequencing technologies offer considerable potential for the explanation of 
unexplained or difficult-to-diagnose diseases. However, current technological capabilities 
and demands for clinical translation seem to outpace current knowledge about the clinical 
validity and utility of many of the gene variants obtained from genomic sequencing. 
Multidisciplinary research aimed at developing guidelines for applying sequencing 
technologies is currently underway, and the need for such research will only increase with 
continuing advances in genomic science and medicine. The experiences and research of 
genetic counselors are crucial to meeting this need.
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Questions about communicating sequencing information and helping patients and families 
understand it can be addressed, in part, by applying research from psychological science to 
genetic counseling research. For example, psychological studies in cognition, 
communication, and decision making suggest that expectations, emotions, and biases in 
thinking about complex and uncertain information can shape patient-provider understanding 
and communication. Psychological studies on cognition, social processes, health, and 
communication suggest that patients' literacy, preferences for information, perspectives on 
their health, and views of different providers are important factors to consider when 
communicating sequencing information. Psychological studies on social processes and 
health also suggest that patient and family responses to uncertainties in genomic information 
may be shaped by individual or family differences in communication and coping 
preferences.
The cited examples of psychological science, as well as the examples of research directions, 
reflect a small subset of psychological theory and research. The breadth of psychological 
research on emotional, cognitive, and behavioral processes span well over a century, making 
an exhaustive review of all of the potential applications of psychological science to clinical 
translation of genomic sequencing impossible. At the same time, this breadth provides a rich 
basis for advancing scientific understanding of patient-provider communication and patients' 
and families' psychological and behavioral responses surrounding the complexities of 
genomic sequencing. Additional examples of psychological science that were not discussed 
but could also inform genetic counseling research include (but are not limited to) the 
literature on illness representations (Marteau and Weinman 2006), stigma (Major and 
O'Brien 2005), locus of control (Cheng, Cheung, Chio, and Chan 2013), and cognitive 
dissonance (Harmon-Jones, Amodio, and Harmon-Jones 2009).
Findings from the psychological science research cited in this paper come from a variety of 
study contexts (e.g., field research, laboratory settings) and participant populations (e.g., 
cancer patients, healthy young adults). The degree to which such findings will replicate in 
the context of clinical genomics is an empirical question. Yet, it is possible that the 
psychological, social, and behavioral implications of sequencing information are much like 
those of other health (e.g., cancer risk) or social (e.g., predicting someone else's behaviors) 
contexts in the sense of being complex, ambiguous, and having unclear long-term 
implications. The richness and breadth of psychological science offers a significant resource 
for genetic counseling research to investigate ways to maximize the benefits and minimize 
the harms of clinical genomic sequencing. Further, the range of different types of research 
methodologies (e.g., quantitative survey research, qualitative observational studies) 
employed in psychological science demonstrate the value of implementing multiple research 
methods to address a wide range of research questions. We hope that the examples of 
psychological science in this paper will generate innovative research that addresses critical 
questions about clinical applications of genomic sequencing technologies and inform genetic 
counseling practice.
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Table 1
Examples of different areas of psychological science (King 2008)
Area Description Examples of research
Cognitive Investigating attention, consciousness, information processing, and 
memory
Learning, decision making
Social Investigating social interactions, relationships, perceptions of 
oneself relative to others, and attitudes
Social support, discrimination
Health Investigating psychological factors affecting health, lifestyle 
behaviors, and health care
Stress and coping, illness management
Personality Investigating enduring individual characteristics Personality traits, motivation
Developmental Investigating factors contributing to human development Language development, aging and memory
Clinical Investigation and treatment of clinical disorders Mental disorder treatments, classification of mental 
disorders
J Genet Couns. Author manuscript; available in PMC 2016 March 03.
